An observational study in Cardiac Surgery, Microplastics and Nanoplastics, sponsored by Kun Hua. Status unknown. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-11-02.
Sponsored by Kun Hua · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The exponential growth in plastic production/use translates into a parallel increase in environmental plastic waste, which is constantly degraded into microplastics and nanoplastics. Information on the effects of microplastics on human health is still preliminary.
Cardiac surgery patients is a population high exposed to plastics. This observational study will obtain biological samples of cardiac surgery patients as a reference and vulnerable group of individuals highly exposed to microplastics and potentially more susceptible.
The objective of this research is to be able to detect microplastics on blood and operation samples of cardiac surgery patients as well as their potential genotoxic and immunological damage.
5,376 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.
This study's planned enrollment of 40 is below the median of 534 across 1,577 observational studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Kun Hua is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Cardiac surgery patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Detection of microplastics/nanoplastics in heart tissue and the blood of patients undergoing cardiac surgery
Other: Microplastics
Detection of microplastics as a yes/no value
Detection of microplastics in human heart tissue and the blood
Detection of microplastics in human heart tissue and the blood undergoing cardiac surgery
Time frame: perioperative: preoperative and pro-/postoperative blood and intraoperative heart tissue
No study locations are listed for this record.
Start is estimated for Nov 2022; primary completion for May 2023, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kun Hua